Amrutanjan Health Care Limited has announced its investor presentation for the quarter and nine months ended December 31, 2025. The company reported a 14.90% growth in revenue from operations for the third quarter of FY26, reaching ₹141.04 crore compared to ₹122.75 crore in the same period last year. Profit Before Tax (PBT) for the quarter stood at ₹26.36 crore, a slight increase from ₹25.99 crore year-on-year. Profit After Tax (PAT) was ₹19.45 crore, up from ₹19.25 crore in Q3 FY25. For the nine months ended December 31, 2025 (YTD Dec’25), revenue from operations grew by 11.50% to ₹352.78 crore from ₹316.40 crore in the corresponding period of the previous fiscal. PBT for the nine-month period increased by 17.79% to ₹56.87 crore, and PAT rose by 17.02% to ₹41.73 crore. The company highlighted strong performance across its power brands. The OTC business (excluding Comfy) grew by 14.3% for the quarter and 14.6% for the nine months. The Comfy brand saw a significant growth of 22.6% in the quarter and 9.6% for the nine months. Management commentary noted that profits for the nine-month period grew by 18% (PBT). Key strategic objectives include driving penetration through strengthening presence in core markets, investing in low-contribution markets, and expanding the product portfolio. The company also focused on increased TV media spends, adopting digital media, on-ground activations, and a rural van drive. A new product, Comfy Slimfit XXL (Night pads), was launched in Q3 FY26. Operations update showed a 16% increase in productive calls and a 10% increase in effective outlet coverage. HR initiatives included updating the code of conduct, launching employee engagement surveys, and training for field employees. The company expressed confidence in ending the year with a strong Q4, continuing the double-digit growth in both top and bottom lines.
